N-terminal domain of myelin basic protein inhibits amyloid beta-protein fibril assembly.
Accumulation of amyloid β-protein (Aβ) into brain parenchymal plaques and the cerebral vasculature is a pathological feature of Alzheimer disease and related disorders. Aβ peptides readily form β-sheet-containing oligomers and fibrils. Previously, we reported a strong interaction between myelin basic protein (MBP) and Aβ peptides that resulted in potent inhibition of fibril assembly (Hoos, M. D., Ahmed, M., Smith, S. O., and Van Nostrand, W. E. (2007) J. Biol. Chem. 282, 9952-9961; Hoos, M. D., Ahmed, M., Smith, S. O., and Van Nostrand, W. E. (2009) Biochemistry 48, 4720-4727). MBP is recognized as a highly post-translationally modified protein. In the present study, we demonstrate that human MBP purified from either brain or a bacterial recombinant expression system comparably bound to Aβ and inhibited Aβ fibril assembly indicating that post-translational modifications are not required for this activity. We also show that purified mouse brain MBP and recombinantly expressed mouse MBP similarly inhibited Aβ fibril formation. Through a combination of biochemical and ultrastructural techniques, we demonstrate that the binding site for Aβ is located in the N-terminal 64 amino acids of MBP and that a stable peptide (MBP1) comprising these residues was sufficient to inhibit Aβ fibrillogenesis. Under conditions comparable with those used for Aβ, the fibrillar assembly of amylin, another amyloidogenic peptide, was not inhibited by MBP1, although MBP1 still bound to it. This observation suggests that the potent inhibitory effect of MBP on fibril formation is not general to amyloidogenic peptides. Finally, MBP1 could prevent the cytotoxic effects of Aβ in primary cortical neurons. Our findings suggest that inhibition of Aβ fibril assembly by MBP, mediated through its N-terminal domain, could play a role in influencing amyloid formation in Alzheimer disease brain and corresponding mouse models.
Liao
Mei-Chen
MC
Department of Neurosurgery and Medicine, Stony Brook University, Stony Brook, New York 11794, USA.
Hoos
Michael D
MD
Aucoin
Darryl
D
Ahmed
Mahiuddin
M
Davis
Judianne
J
Smith
Steven O
SO
Van Nostrand
William E
WE
D000595:Amino Acid Sequence; D000682:Amyloid / Q000737:chemistry / Q000378:metabolism* / Q000648:ultrastructure; D016229:Amyloid beta-Peptides / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D001921:Brain / Q000378:metabolism; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004926:Escherichia coli / Q000235:genetics; D006801:Humans; D051379:Mice; D018625:Microscopy, Atomic Force; D046529:Microscopy, Electron, Transmission; D008969:Molecular Sequence Data; D004676:Myelin Basic Protein / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D009474:Neurons / Q000166:cytology / Q000187:drug effects; D010446:Peptide Fragments / Q000235:genetics / Q000378:metabolism*; D011485:Protein Binding; D051381:Rats; D011994:Recombinant Proteins / Q000378:metabolism / Q000494:pharmacology; D020349:Surface Plasmon Resonance
D000682:Amyloid; D016229:Amyloid beta-Peptides; D004676:Myelin Basic Protein; D010446:Peptide Fragments; D011994:Recombinant Proteins
Biochemistry. 2007 Aug 28;46(34):9805-12
17676931
Exp Cell Res. 1989 Aug;183(2):484-93
2670595
J Biol Chem. 1992 Jan 5;267(1):546-54
1730616
Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10695-9
7504278
J Neurosci Res. 2002 Sep 1;69(5):567-77
12210822
Stroke. 1987 Mar-Apr;18(2):311-24
3551211
Physiol Rev. 2001 Apr;81(2):741-66
11274343
J Neurosci. 2008 Feb 13;28(7):1537-45
18272675
J Neuropathol Exp Neurol. 2003 Dec;62(12):1287-301
14692704
J Neurosci Res. 1987;17(4):321-8
2442403
Biochem Soc Trans. 2002 Aug;30(4):552-7
12196135
Biochemistry. 1998 Feb 24;37(8):2441-9
9485392
J Biol Chem. 2007 Mar 30;282(13):9952-9961
17259179
J Neurosci Res. 1988 Sep;21(1):62-70
2464072
J Neural Transm (Vienna). 2002 May;109(5-6):813-36
12111471
J Neurosci Res. 2000 Jan 15;59(2):153-9
10650873
Proc Natl Acad Sci U S A. 1987 Jun;84(12):4190-4
3035574
Physiol Rev. 2001 Apr;81(2):871-927
11274346
J Biol Chem. 2001 Aug 31;276(35):32860-6
11441013
Nature. 1987 Feb 19-25;325(6106):733-6
2881207
J Cell Biochem. 1994;55 Suppl:39-53
7929617
Nat Struct Mol Biol. 2010 May;17(5):561-7
20383142
J Biol Chem. 2003 Mar 28;278(13):11612-22
12499373
Science. 1990 Jun 1;248(4959):1124-6
2111584
Biochemistry. 2009 Jun 9;48(22):4720-7
19385666
Nature. 2002 Apr 4;416(6880):535-9
11932745
Micron. 2004;35(7):503-42
15219899
Ann Neurol. 2001 Jun;49(6):697-705
11409420
Science. 1987 Feb 20;235(4791):880-4
2949367
J Neurosci. 1993 Apr;13(4):1676-87
8463843
Proc Natl Acad Sci U S A. 1985 Jun;82(12):4245-9
3159021
Science. 1990 Jun 1;248(4959):1120-2
1971458
J Am Chem Soc. 2008 May 21;130(20):6424-9
18444645
Am J Hum Genet. 1992 Nov;51(5):998-1014
1415269
Biochemistry. 2005 Dec 13;44(49):16284-91
16331989
Science. 1996 Oct 4;274(5284):99-102
8810256
Nat Genet. 1992 Jun;1(3):218-21
1303239
J Biol Chem. 2000 Sep 1;275(35):27110-6
10821838
J Biol Chem. 1989 Mar 25;264(9):5121-7
2466844
Science. 1987 Feb 20;235(4791):877-80
3810169
J Biol Chem. 1993 Mar 5;268(7):4930-8
7680345
Cell. 1985 Dec;43(3 Pt 2):721-7
2416470
J Biol Chem. 2004 May 7;279(19):20296-306
14985348
J Neurochem. 1978 Oct;31(4):779-82
81270